SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-167729
Filing Date
2020-06-12
Accepted
2020-06-12 16:30:02
Documents
6
Effectiveness Date
2020-06-12

Document Format Files

Seq Description Document Type Size
1 DEFA14A d859259ddefa14a.htm DEFA14A 34866
2 GRAPHIC g859259gra002.jpg GRAPHIC 2356
3 GRAPHIC g859259gra004.jpg GRAPHIC 8390
4 GRAPHIC g859259gra005.jpg GRAPHIC 8400
5 GRAPHIC g859259sp001.jpg GRAPHIC 1328
6 GRAPHIC g859259sp002.jpg GRAPHIC 1315
  Complete submission text file 0001193125-20-167729.txt   55955
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33500 | Film No.: 20960537
SIC: 2834 Pharmaceutical Preparations